UroGen Pharma Ltd.【URGN】 業績推移・財務諸表

(単位:千ドル) 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25
売上高 - - 18 - - - 372 3,461 7,485 13,032 11,351 13,564 16,604 16,097 17,192 21,139 20,852 18,781 21,848 25,204 24,565 20,254 24,215
売上成長率(%) - - - - - - - - -
売上原価 - - - - - - 48 309 897 1,427 1,244 1,525 1,846 2,020 2,265 2,443 2,367 1,728 2,229 2,453 - 2,330 3,550
売上総利益 - - 18 - - - 324 3,152 6,588 11,605 10,107 12,039 14,758 14,077 14,927 18,696 18,485 17,053 19,619 22,751 22,094 17,924 20,665
売上総利益率(%) - - - - -
研究開発費 - - 9,996 9,481 - 16,588 8,106 10,211 10,513 12,124 11,923 12,696 12,640 13,093 12,498 11,584 10,230 15,494 15,402 11,355 - 19,871 18,914
販売管理費 - - - - - 21,973 24,018 22,065 22,189 22,304 21,624 21,300 20,833 19,071 24,474 22,494 21,755 27,299 30,056 28,941 - 34,967 43,199
営業利益 -24,017 -22,433 -23,753 -23,453 -39,839 -38,561 -31,800 -29,124 -26,114 -22,823 -23,440 -21,957 -18,715 -18,087 -22,045 -15,382 -13,500 -25,740 -25,839 -17,545 - -36,914 -41,448
営業利益率 (%) - - - - - -
経常(税引前)利益 - - - - - - - - - -25,910 -30,211 -28,067 -26,659 -25,122 -30,192 -24,082 -21,888 -32,232 -33,365 -23,582 - -43,451 -48,925
経常(税引前)利益率(%) - - - - - - - - - -198.82 -266.15 -206.92 -160.56 -156.07 -175.62 -113.92 -104.97 -171.62 -152.71 -93.56 - -214.53 -202.04
法人税等合計 - - - - - - - - - 312 - 325 32 709 21 54 -9 54 38 91 - 392 1,015
実効税率(%) - - - - - - - - - - -
純利益 -23,716 -21,444 -22,477 -22,252 -38,973 -37,793 -31,349 -28,816 -25,935 -26,222 -30,211 -28,392 -26,691 -25,831 -30,213 -24,136 -21,879 -32,286 -33,403 -23,673 -37,512 -43,843 -49,940
純利益率(%) - - - - -
一株あたり利益 - - - - - - - - - - - -1.25 -1.18 -1.13 -1.3 -1.03 -0.68 -0.97 -0.91 -0.55 -0.8 -0.92 -1.05
希薄化後一株あたり利益 - - - - - - - - - - - -1.25 -1.18 -1.13 -1.3 -1.03 -0.68 -0.97 -0.91 -0.55 -0.8 -0.92 -1.05
EBITDA - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - -